Bioservo Technologies AB Registered Shs Aktie

Bioservo Technologies AB Registered Shs für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2DSXU / ISIN: SE0009779085

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
28.10.2020 12:13:00

Bioservo signs distribution agreement with G-Hoo in South Korea

STOCKHOLM, Oct. 28, 2020 /PRNewswire/ -- Bioservo Technologies AB has signed a distribution agreement with G-Hoo Corporation Inc for selling Ironhand® in South Korea.

G-HOO has during the last 20 years played a pivotal role in the Korean automotive industry as well as in general industries. They are focusing on improving their customers production processes by developing and implementing robotics systems based on industrial robots. When developing robotic systems, they take care of the entire process from installing, test-driving, and teaching to overhauling industrial robots. With their technical capacity and reliability, they are acknowledged in Korea and overseas. They are constantly striving to develop new techniques through their own technology research center.

"G-Hoo are experienced in providing leading edge solutions for both the automotive and other industries and we are pleased that they now will include Ironhand® into their portfolio. South Korea is an interesting market with large companies within our focused industry segments, and this is in line with our efforts to strengthen our presence in Asia.", Says Petter Bäckgren, CEO at Bioservo.

About Bioservo Technologies

Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy and efficient.

The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength.

Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.

FNCA Sweden AB, +46(0)8 528 00399, info@fnca.se is the Company's Certified Adviser on Nasdaq First North Growth Market.

For more information, please visit www.bioservo.com

 

For more information, please contact

Petter Bäckgren
CEO of Bioservo Technologies AB
Phone: +46 (0)8 21 17 10
petter.backgren@bioservo.com

Mikael Wester
Marketing Director of Bioservo Technologies AB
Phone: +46 (0)8 21 17 10
mikael.wester@bioservo.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bioservo-technologies-ab--publ-/r/bioservo-signs-distribution-agreement-with-g-hoo-in-south-korea,c3226947

 

Nachrichten zu Bioservo Technologies AB Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Bioservo Technologies AB Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!